Human Molecular Genetics, 2003, Vol. 12, No. 10 1111-1120
DOI: 10.1093/hmg/ddg131
© 2003 Oxford University Press
New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12
1International Centre for Genetic Engineering and Biotechnology, Padriciano 99, Trieste 34012, Italy, 2Department of Medical Genetics, Athens University, ‘Aghia Sophia’ Children's Hospital, Thivon and Livadias, Athens 11527, Greece, 3Cystic Fibrosis Department, ‘Aghia Sophia’ Children's Hospital, Athens, Greece and 4Centro de Genética Medica y Molecular, Instituto Recerca Oncológica (IRO), Hospital Duran y Reynals, Gran Via s/n km 2,7 08907 Barcelona, Spain
Received December 16, 2002; Accepted March 17, 2003
The increase in genome scanning data, derived from clinical genetics practice, is producing a wealth of information on human sequence variability. The critical issue is to identify if a given nucleotide change results in a benign polymorphism or a disease-causing mutation. We have focused on one specific gene expression step, pre-mRNA processing, where we can functionally define the effect of nucleotide changes and in turn the patient's mutation can shed light on the basic pre mRNA splicing mechanisms. Our results show that several nucleotide changes in CFTR exon 12 induce a variable extent of exon skipping that leads to reduced levels of normal transcripts. This is the case in both natural mutations D565G and G576A (the latter having previously considered a neutral polymorphism) and several site-directed silent substitutions. We demonstrate here that this phenomenon is due to the interference with a new regulatory element that we have named composite exonic regulatory element of splicing (CERES). The effect of single nucleotide substitutions at CERES cannot be predicted by neither SR matrices nor enhancer identification. The recognition and characterization of splicing abnormalities, caused by exon sequence variations at CERES elements, may represent a frequent disease-causing mechanism that also relates to the phenotypic variability. Our results indicate that even the most benign looking polymorphism in an exon cannot be ignored as it may affect the splicing process. Hence, appropriate functional splicing assays should be included in genotype screenings to distinguish between polymorphisms and pathogenic mutations.
* To whom correspondence should be addressed. Tel: +39 0403757337; Fax: +39 0403757361; Email: baralle{at}icgeb.org
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Pastor, G. Talotti, M. A. Lewandowska, and F. Pagani An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM Nucleic Acids Res., November 18, 2009; (2009) gkp778v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Haque, E. Buratti, and F. E. Baralle Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12 Nucleic Acids Res., November 12, 2009; (2009) gkp1040v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Burgess, R E MacLaren, A E Davidson, J E Urquhart, G E Holder, A G Robson, A T Moore, R O Keefe, G C M Black, and F D C Manson ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing J. Med. Genet., September 1, 2009; 46(9): 620 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A Hahn, J. McDonnell, and D. J Marsh The effect of disease-associated HRPT2 mutations on splicing J. Endocrinol., June 1, 2009; 201(3): 387 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kaufmann, S. Vogt, S. Uhlhaas, D. Stienen, I. Kurth, H. Hameister, E. Mangold, J. Kotting, E. Kaminsky, P. Propping, et al. Analysis of Rare APC Variants at the mRNA Level: Six Pathogenic Mutations and Literature Review J. Mol. Diagn., March 1, 2009; 11(2): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Coles, M. Hallegger, and C. W.J. Smith A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F RNA, January 1, 2009; 15(1): 33 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Goina, N. Skoko, and F. Pagani Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant Mol. Cell. Biol., June 1, 2008; 28(11): 3850 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gromak, G. Talotti, N. J. Proudfoot, and F. Pagani Modulating alternative splicing by cotranscriptional cleavage of nascent intronic RNA RNA, February 1, 2008; 14(2): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gromoll, L. Lahrmann, M. Godmann, T. Muller, C. Michel, S. Stamm, and M. Simoni Genomic Checkpoints for Exon 10 Usage in the Luteinizing Hormone Receptor Type 1 and Type 2 Mol. Endocrinol., August 1, 2007; 21(8): 1984 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Raponi, F. E. Baralle, and F. Pagani Reduced splicing efficiency induced by synonymous substitutions may generate a substrate for natural selection of new splicing isoforms: the case of CFTR exon 12 Nucleic Acids Res., January 28, 2007; 35(2): 606 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Tran, Y. Takeshima, Z. Zhang, M. Yagi, A. Nishiyama, Y. Habara, and M. Matsuo Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene J. Med. Genet., December 1, 2006; 43(12): 924 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Disset, C.F. Bourgeois, N. Benmalek, M. Claustres, J. Stevenin, and S. Tuffery-Giraud An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements Hum. Mol. Genet., March 15, 2006; 15(6): 999 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Singh, N. N. Singh, E. J. Androphy, and R. N. Singh Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron Mol. Cell. Biol., February 15, 2006; 26(4): 1333 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kralovicova and I. Vorechovsky Position-Dependent Repression and Promotion of DQB1 Intron 3 Splicing by GGGG Motifs J. Immunol., February 15, 2006; 176(4): 2381 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S McVety, L Li, P H Gordon, G Chong, and W D Foulkes Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family J. Med. Genet., February 1, 2006; 43(2): 153 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Meyer and I. Miklos Statistical evidence for conserved, local secondary structure in the coding regions of eukaryotic mRNAs and pre-mRNAs Nucleic Acids Res., November 7, 2005; 33(19): 6338 - 6348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Baralle and M Baralle Splicing in action: assessing disease causing sequence changes J. Med. Genet., October 1, 2005; 42(10): 737 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, P. J. Smith, A. R. Krainer, and M. Q. Zhang Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes Nucleic Acids Res., September 7, 2005; 33(16): 5053 - 5062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lei, I. N. M. Day, and I. Vorechovsky Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer Nucleic Acids Res., July 14, 2005; 33(12): 3897 - 3906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pagani, M. Raponi, and F. E. Baralle Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution PNAS, May 3, 2005; 102(18): 6368 - 6372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kralovicova, S. Houngninou-Molango, A. Kramer, and I. Vorechovsky Branch site haplotypes that control alternative splicing Hum. Mol. Genet., December 15, 2004; 13(24): 3189 - 3202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. SINGH, E. J. ANDROPHY, and R. N. SINGH In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes RNA, August 1, 2004; 10(8): 1291 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. ITOH, T. WASHIO, and M. TOMITA Computational comparative analyses of alternative splicing regulation using full-length cDNA of various eukaryotes RNA, July 1, 2004; 10(7): 1005 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Lastella, N Resta, I Miccolis, A Quagliarella, G Guanti, and A Stella Site directed mutagenesis of hMLH1 exonic splicing enhancers does not correlate with splicing disruption J. Med. Genet., June 1, 2004; 41(6): e72 - e72. [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, A. F. Muro, M. Giombi, D. Gherbassi, A. Iaconcig, and F. E. Baralle RNA Folding Affects the Recruitment of SR Proteins by Mouse and Human Polypurinic Enhancer Elements in the Fibronectin EDA Exon Mol. Cell. Biol., February 1, 2004; 24(3): 1387 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pagani, E. Buratti, C. Stuani, and F. E. Baralle Missense, Nonsense, and Neutral Mutations Define Juxtaposed Regulatory Elements of Splicing in Cystic Fibrosis Transmembrane Regulator Exon 9 J. Biol. Chem., July 11, 2003; 278(29): 26580 - 26588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cartegni, J. Wang, Z. Zhu, M. Q. Zhang, and A. R. Krainer ESEfinder: a web resource to identify exonic splicing enhancers Nucleic Acids Res., July 1, 2003; 31(13): 3568 - 3571. [Abstract] [Full Text] [PDF]
|
|